14.08.2023 13:16:41

Bio-Techne, Akoya To End Co-development Of RNAscope For Use With PhenoCycler-Fusion System

(RTTNews) - Life sciences company Bio-Techne Corp. (TECH) announced Monday that the company will end their collaboration with Akoya Biosciences to co-develop an automated RNAscope workflow for use with the PhenoCycler-Fusion System. The decision was made following best efforts to achieve the intended program goals.

Bio-Techne said it plans to accelerate the development and commercialization of the first fully automated and scalable spatial multiomics workflow on the Lunaphore COMET system.

Bio-Techne will continue to support its customers utilizing RNAscope assays in conjunction with Opal reagents and PhenoImager HT systems purchased from Akoya.

Analysen zu Bio-Techne Corpmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Bio-Techne Corp 55,50 -0,89% Bio-Techne Corp